Budesonide (Compound)

Synonyms:budesonide, Pulmicort, Entocort, Rhinocort, 51333-22-3, Preferid, Rhinocort Aqua, Entocort EC, Uceris, Pulmicort Respules, Budeson, Pulmicort Flexhaler, Cortivent, Micronyl, Respules, Spirocort, Bidien, S-1320, MAP-0010, CHEBI:3207, 51372-29-3, Q3OKS62Q6X, MLS000028507, (RS)-11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with butyraldehyde, Budesonide MMX, Budesonidum, DTXSID8020202, Rhinocort alpha, MAP0010, R01AD05, (11beta,16alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione, 16A(R),17-(BUTYLIDENEBIS(OXY))-11B,21-DIHYDROXYPREGNA-1,4-DIENE-3,20-DIONE, NSC-757788, Budenofalk, Budesonido, SMR000058337, Budecort Inhaler, Budesonidum [INN-Latin], Budesonido [INN-Spanish], DTXCID50820058, (R)-Budesonide, Inflammide, Budiair, Miflonide, Pulmaxan, Fvolir, 16,17-Butylidenebis(oxy)-11,21-dihydroxypregna-1,4-diene-3,20-dione, (22R)-Budesonide, Budesonide [USAN:INN:BAN:JAN], Rhinocort Allergy, Pulmaxan turbohaler, Pulmicort (TN), Pulmicort Topinasal, Rhinocort (TN), (1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-propyl-5,7-dioxapentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icosa-14,17-dien-16-one, Pulmicort turbuhaler, Budesonide Easyhaler, S 1320, CCRIS 5230, Entocort EC (TN), SR-01000000101, EINECS 257-139-7, MFCD00083259, UNII-Q3OKS62Q6X, Jorveza, Eltair, Ultesa, Noex, Giona Easyhaler, 16?,17-[(1RS)-Butylidenebis(oxy)]-11?,21-dihydroxypregna-1,4-diene-3,20-dione, NCGC00016862-01, Pregna-1,4-diene-3,20-dione, 16,17-[butylidenebis(oxy)]-11,21-dihydroxy-, (11.beta.,16.alpha.)-, Prestwick_840, CAS-51333-22-3, Uceris (TN), ORTIKOS, (11-beta,16-alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione, 16-alpha,17-alpha-Butylidenedioxy-11-beta,21-dihydroxy-1,4-pregnadiene-3,20-dione, Budesonide, >=99%, BUDESONIDE [MI], BUDESONIDE [INN], BUDESONIDE [JAN], Opera_ID_1696, Prestwick0_000518, Prestwick1_000518, Prestwick2_000518, Prestwick3_000518, BUDESONIDE [USAN], BUDESONIDE [VANDF], Epitope ID:161750, B 7777, SCHEMBL4096, (+)-16alpha,17alpha-Butylidenedioxy-11beta,21-dihydroxy-1,4-pregnadiene-3,20-dione, BUDESONIDE [USP-RS], BUDESONIDE [WHO-DD], CHEMBL1370, Pregna-1,4-diene-3,20-dione,16,17-(butylidenebis(oxy))-11,21-dihydroxy-, (11beta,16alpha)-, Lopac0_000174, BSPBio_000475, Budesonide (JAN/USP/INN), MLS001077323, MLS002207112, Budesonide (anti-inflammatory), SPBio_002396, BPBio1_000523, GTPL7434, BUDESONIDE [ORANGE BOOK], HSDB 8279, BUDESONIDE [EP MONOGRAPH], UCERIS COMPONENT BUDESONIDE, BUDESONIDE [USP MONOGRAPH], HMS1569H17, HMS2096H17, HMS2232D17, HMS3259H07, HMS3260D09, HMS3413B08, HMS3413P17, HMS3677B08, HMS3677P17, HMS3713H17, BREZTRI COMPONENT BUDESONIDE, 5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one, ACT03247, AIRSUPRA COMPONENT BUDESONIDE, BCP05589, Eohilia (budesonide oral suspension), Tox21_110653, Tox21_201827, Tox21_302815, Tox21_500174, BDBM50354850, SYMBICORT COMPONENT BUDESONIDE, BUDESONIDE COMPONENT OF UCERIS, AKOS015969655, BUDESONIDE COMPONENT OF BREZTRI, AC-4697, BUDESONIDE COMPONENT OF AIRSUPRA, CCG-204269, CS-2063, DB01222, KS-1162, LP00174, NC00626, NSC 757788, SDCCGSBI-0050162.P002, 11beta,21-dihydroxy-16alpha,17alpha-(butane-1,1-diyldioxy)pregna-1,4-diene-3,20-dione, BUDESONIDE COMPONENT OF SYMBICORT, NCGC00021318-05, NCGC00021318-06, NCGC00021318-08, NCGC00021318-18, NCGC00089747-04, NCGC00256415-01, NCGC00259376-01, NCGC00260859-01, BB164267, Budesonide 100 microg/mL in Acetonitrile, CPD000058337, HY-13580, Pregna-1,4-diene-3,20-dione, 16,17-(butylidenebis(oxy))-11,21-dihydroxy-, (11-beta,16-alpha)-, Pregna-1,4-diene-3,20-dione, 16,17-butylidenebis(oxy)-11,21-dihydroxy-, (11beta,16alpha(R))-, and 16alpha,17-((S)-Butylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dione, B3909, EU-0100174, D00246, T70986, EN300-19737584, Q422212, J-504150, Q-101375, SR-01000000101-2, SR-01000000101-6, BRD-A34299591-001-03-4, Budesonide, European Pharmacopoeia (EP) Reference Standard, Budesonide, United States Pharmacopeia (USP) Reference Standard, Budesonide, Pharmaceutical Secondary Standard; Certified Reference Material, (11?,16?)-16,17-[Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione, (4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-6b-Glycoloyl-5-hydroxy-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one, (6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-10-propyl-1,2,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-4H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4-one

Pubchem:PUBCHEM:5281004

Id:3059fe70-cb28-5478-b830-9c81b69a3b61

Description:nan